Buck, Benjamin http://orcid.org/0000-0003-2841-0493
Kopelovich, Sarah L.
Tauscher, Justin S.
Chwastiak, Lydia
Ben-Zeev, Dror
Funding for this research was provided by:
National Institute of Mental Health (K23MH122504, R01MH116057)
Article History
Received: 6 April 2022
Revised: 15 July 2022
Accepted: 21 July 2022
First Online: 3 August 2022
Declarations
:
: The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the University of Washington (IRB#STUDY00006141, Initial approval: 11/27/2018).
: Informed consent was obtained from all individual participants in the study.
: Dr. Ben-Zeev has financial interests in Merlin LLC, FOCUS technology, and CORE technology. He has an intervention content licensing agreement with Pear Therapeutics and has provided consultation services to Trusst Health, K Health, Boehringer Ingelheim, eQuility, Deep Valley Labs, and Otsuka Pharmaceuticals.